Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 25.05.2026 3 Am Heart J 2 Am J Cardiol 1 Am J Emerg Med 1 Am J Med 2 Angiology 1 Ann Intern Med 1 Arterioscler Thromb Vasc Biol 3 Atherosclerosis 3 Can J Cardiol 2 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 1 Circ Res 9 Circulation 1 Clin Cardiol 2 Eur Heart J 3 Hypertension 2 Int J Cardiol 4 J Am Coll Cardiol 2 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 1 JAMA 2 Lancet 1 N Engl J Med 1 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. HOSSEINI F, Kang M, Segal T, Singer J, et al
   Impact of Malnutrition on Outcomes among elderly ST-Elevation Myocardial Infarction Patients receiving Primary PCI.
   Am Heart J. 2026 May 15:107489. doi: 10.1016/j.ahj.2026.107489.
   PubMed         Abstract available
   
   
2. CHI KY, Karthikeyan A, Chang Y, Lee PL, et al
   Direct Oral Anticoagulant Monotherapy versus Combination Therapy with Antiplatelets in Chronic Coronary Syndrome Patients with Prior Percutaneous Coronary Intervention Requiring Anticoagulation: A Meta-Analysis.
   Am Heart J. 2026 May 17:107492. doi: 10.1016/j.ahj.2026.107492.
   PubMed         Abstract available
   
   
3. KORJIAN S, Gibson CM, Seltzer J, Mahaffey KW, et al
   Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside.
   Am Heart J. 2026 May 16:107487. doi: 10.1016/j.ahj.2026.107487.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

4. OLIVEIRA VMR, Barbosa LM, Alcantara RWA, Tartuce Filho PRF, et al
   Immediate Aspirin Discontinuation Following Percutaneous Coronary Intervention for Acute Coronary Syndromes.
   Am J Cardiol. 2026 May 20:S0002-9149(26)00238.
   PubMed        
   
   
5. SARA JDS, Carvalho PEP, Seto A, Shlofmitz E, et al
   Intracoronary Imaging for Percutaneous Coronary Intervention Guidance.
   Am J Cardiol. 2026 May 16:S0002-9149(26)00345.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

6. MCKNIGHT KH, Snavely AC, Paukner L, Ashburn NP, et al
   Sex differences in acute chest pain care in a multisite U.S. emergency department cohort.
   Am J Emerg Med. 2026;105:158-163.
   PubMed         Abstract available
   
   

   
   Am J Med

7. VALERIANI E, Marcucci R, Di Nisio M, Calabro P, et al
   Age-related efficacy of aspirin in secondary prevention of coronary artery disease: START-ANTIPLATELET registry and meta-analysis of randomized trials.
   Am J Med. 2026 May 20:S0002-9343(26)00432-8. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Angiology

8. CHANG T, He Y, Ling Y, Zhou Z, et al
   Relationship Between the Aggregate Index of Systemic Inflammation and the prognosis in Patients With CAD and CKD.
   Angiology. 2026;77:752-761.
   PubMed         Abstract available
   
   
9. AYDIN F, Murat B, Murat S
   Association of the Scottish Inflammatory Prognostic Score With the No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
   Angiology. 2026 May 21:33197261448371. doi: 10.1177/00033197261448371.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

10. ATALLA M, Gupta V, Khalid M, Kussmaul WG, et al
    Cardiology: What You May Have Missed in 2025.
    Ann Intern Med. 2026;179.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

11. UELAND T, Dahl TB, Michelsen A, Kleveland O, et al
    Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.
    Arterioscler Thromb Vasc Biol. 2026;46:e323587.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

12. YAVARI N, Wai KM, Alsoudi AF, Koo E, et al
    Xanthelasma and its association with developing major cardio-cerebrovascular events.
    Atherosclerosis. 2026;416:120647.
    PubMed         Abstract available
    
    
13. ARAI T, Sakai K, Mori H, Mizukami T, et al
    Association of the residual SYNTAX score on clinical outcomes in patients with acute coronary syndrome.
    Atherosclerosis. 2026;416:120689.
    PubMed         Abstract available
    
    
14. LI L, Malik R, Abrahamian C, von Scheidt M, et al
    Common and distinct genetic features of three atherosclerotic cardiovascular diseases.
    Atherosclerosis. 2026;416:120733.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

15. RUEL M, Chong AY, Grudzinski AL, Pritchard K, et al
    Stop the Invasion-Advances in Myocardial Revascularization.
    Can J Cardiol. 2026;42.
    PubMed         Abstract available
    
    
16. BOIVIN-PROULX LA, So DYF, Tulloch H, Heshka J, et al
    A Woman's Heart: The Microvascular Disease Dilemma.
    Can J Cardiol. 2026;42.
    PubMed         Abstract available
    
    
17. MCPHERSON R
    Genetics and Genomics of Coronary Artery Disease: What We Have Learned.
    Can J Cardiol. 2026;42.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

18. BALDASSARRE LA, Mendes LA, Blankstein R, Hahn RT, et al
    Correction to: 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
    Circ Cardiovasc Imaging. 2026;19:e000091.
    PubMed        
    
    
19. OBERHOLLENZER F, Lechner I, Tiller C, Holzknecht M, et al
    Coronary Culprit Lesion Location and Intramyocardial Hemorrhage in STEMI.
    Circ Cardiovasc Imaging. 2026;19:e019364.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

20. ARAI T, Sakai K, Ikeda K, Mizukami T, et al
    Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease.
    Circ Cardiovasc Interv. 2026 May 20:e016735.
    PubMed         Abstract available
    
    
21. SAMMOUR YM, Spertus JA, Smilowitz NR, Dong H, et al
    Hospital-Level Variability in NSTEMI Management: Findings From the NCDR Chest Pain-MI Registry.
    Circ Cardiovasc Interv. 2026;19:e016534.
    PubMed         Abstract available
    
    

    
    Circ Res

22. LARCHER V, Fischer A, Zhang L, Almolla O, et al
    Leptin Receptor Fibroblasts Are Preferential Contributors to Cardiac Fibrosis.
    Circ Res. 2026;138:e327701.
    PubMed         Abstract available
    
    

    
    Circulation

23. PAN Y, Ding J
    Letter by Pan and Ding Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1336-e1337.
    PubMed        
    
    
24. ABBOTT JD, Benatar JR, Ballantyne CM, Jacobs AK, et al
    Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.
    Circulation. 2026 May 18. doi: 10.1161/CIRCULATIONAHA.125.078320.
    PubMed         Abstract available
    
    
25. FISTER M, Noc M, Radsel P, Bunc M, et al
    Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial.
    Circulation. 2026;153:1526-1534.
    PubMed         Abstract available
    
    
26. BALLIN M, Carlsson AC, Wandell P, Ahlqvist VH, et al
    Adolescent Cardiorespiratory Fitness and the Trade-Off Between Atrial Fibrillation Risk and Cardiovascular Benefits: A Nationwide Sibling-Controlled Cohort Study.
    Circulation. 2026 May 21. doi: 10.1161/CIRCULATIONAHA.125.078250.
    PubMed         Abstract available
    
    
27. MAC GRORY B, Yeh RW, Beckman JA, Kamel H, et al
    Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 20. doi: 10.1161/CIR.0000000000001440.
    PubMed         Abstract available
    
    
28. BERGMARK BA, Bohula EA, Marston NA, Park JG, et al
    Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
    Circulation. 2026 May 19. doi: 10.1161/CIRCULATIONAHA.126.080616.
    PubMed         Abstract available
    
    
29. LALANI C, Dahabreh IJ, Cohen DJ, Kazi DS, et al
    Evaluating Cardiovascular Devices Using Observational Analyses.
    Circulation. 2026;153:1573-1592.
    PubMed         Abstract available
    
    
30. DESPRES JP, Neeland IJ
    Incretin-Based Therapies and Cardiovascular Outcomes: Beyond Weight Loss.
    Circulation. 2026;153:1523-1525.
    PubMed        
    
    
31. CHEN BY, Duan SZ
    Response by Chen and Duan to Letter Regarding Article, "Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells".
    Circulation. 2026;153:e1338-e1339.
    PubMed        
    
    

    
    Clin Cardiol

32. AKHTER J, Abedin ZU, Ali H, Khan A, et al
    Pre-Hospital Delay in STEMI: A Narrative Review of Symptom Onset-to-First Medical Contact Across High-Income and Low- and Middle-Income Countries.
    Clin Cardiol. 2026;49:e70352.
    PubMed         Abstract available
    
    

    
    Eur Heart J

33. BUSCHER A, Plagwitz L, Yildirim K, Brix TJ, et al
    Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department.
    Eur Heart J. 2025 Mar 29:ehaf254. doi: 10.1093.
    PubMed         Abstract available
    
    
34. AN KR, Vervoort D, Qiu F, Tam DY, et al
    Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting.
    Eur Heart J. 2025 Nov 25:ehaf806. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Hypertension

35. YANES CARDOZO LL, Romero DG
    Invisible Scar: Why Pregnancy History Matters for Women's Cardiovascular Health.
    Hypertension. 2026;83:e26834.
    PubMed        
    
    
36. SANGARALINGHAM SJ, Burnett JC Jr
    C-Type Natriuretic Peptide and Cardiovascular-Renal Protection in Sepsis.
    Hypertension. 2026;83:e26731.
    PubMed        
    
    
37. MATE-KOLE MN, Zhang M, Turkson-Ocran RN, Kwapong FL, et al
    Orthostatic Blood Pressure, Cardiovascular Disease, and Hypotensive Events.
    Hypertension. 2026 May 20. doi: 10.1161/HYPERTENSIONAHA.125.25773.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

38. KUBIK S
    Prognostic significance of provocation spasm testing in patients with myocardial infarction with and without obstructive coronary arteries.
    Int J Cardiol. 2026 May 20:134572. doi: 10.1016/j.ijcard.2026.134572.
    PubMed        
    
    
39. SKI CF, Thompson DR, Jennings CS, Kotseva K, et al
    Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.
    Int J Cardiol. 2026 May 20:134563. doi: 10.1016/j.ijcard.2026.134563.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

40. LINDLEY KJ, Bello NA, Berlacher KL, Hameed AB, et al
    Optimization of Postpartum Care for Patients With and at Risk for Premature and Long-Term Cardiovascular Disease: 2026 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2026 May 22:S0735-1097(25)10149.
    PubMed        
    
    
41. HATHERLEY J, Dakshi A, Collinson P, Miller G, et al
    Accelerated Diagnostic Pathways for Suspected Acute Coronary Syndrome in Practice: A Randomized Trial of 0/1-Hour vs 0/3-Hour Troponin Testing.
    J Am Coll Cardiol. 2026 May 3:S0735-1097(26)05979.
    PubMed         Abstract available
    
    
42. BLAHA MJ
    Expansion of the Guideline-Recommended Role for Coronary Artery Calcium: Initiation and Intensification of Lipid-Lowering Therapy.
    J Am Coll Cardiol. 2026;87:2597-2599.
    PubMed        
    
    
43. BROOK RD, Rajagopalan S
    Air Pollution-Induced Cardiovascular Disease: Moving From Mechanisms to Decisive Action.
    J Am Coll Cardiol. 2026 Apr 27:S0735-1097(26)06135.
    PubMed        
    
    

    
    J Mol Cell Cardiol

44. YAN Y, Huang Y, Cao C, Li D, et al
    OSK-mediated partial reprogramming induces cardiomyocyte dedifferentiation, overcomes cytokinesis barriers, and promotes post-MI endogenous cardiac regeneration.
    J Mol Cell Cardiol. 2026;215:36-50.
    PubMed         Abstract available
    
    
45. CHEN Y, Zheng L, Xiong C, Wang Z, et al
    Small-molecule cocktail 5SM induces heart regeneration by upregulating TGFbeta/BMP signaling.
    J Mol Cell Cardiol. 2026;215:20-35.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

46. ALCUDIA A, Adams G, Kumar S, Moser GW, et al
    For-profit hospitals deliver lower coronary artery bypass graft value: National evidence on mortality and Medicare expenditures.
    J Thorac Cardiovasc Surg. 2026 May 4:S0022-5223(26)00904.
    PubMed         Abstract available
    
    

    
    JAMA

47. ANDERER S
    Cognitive Decline May Precede Cardiovascular Events by Up to 8 Years.
    JAMA. 2026 May 15. doi: 10.1001/jama.2026.6183.
    PubMed        
    
    

    
    Lancet

48. LEE JM, Lee SH, Gim DH, Lee SY, et al
    Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea.
    Lancet. 2026 May 21:S0140-6736(26)00666-5. doi: 10.1016/S0140-6736(26)00666.
    PubMed         Abstract available
    
    
49. ESCANED J, Mejia-Renteria H
    Microvascular dysfunction in atherosclerotic coronary disease.
    Lancet. 2026 May 21:S0140-6736(26)00862-7. doi: 10.1016/S0140-6736(26)00862.
    PubMed        
    
    

    
    N Engl J Med

50. BIOLA H, Khan SS, Lloyd-Jones D, Pagidipati NJ, et al
    Cardiovascular Risk Factors - Hypertension.
    N Engl J Med. 2026 May 20. doi: 10.1056/NEJMp2516850.
    PubMed        
    
    

    
    Prog Cardiovasc Dis

51. SLIPCZUK L
    Integrating structure, data, and prevention in modern cardiovascular care.
    Prog Cardiovasc Dis. 2026 May 20:S0033-0620(26)00045.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum